Day: December 22, 2020

TAMPA, FL, Dec. 22, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Sports Venues of Florida, Inc., (OTCMKTS: BTHR) (“Sports Venues of Florida”, “BTHR”, or the “Company”), an emerging leader in the youth sports, family sports entertainment, and eSports markets, is excited to announce its wholly owned subsidiary Shadow Gaming, Inc. announcing our last two events’ fantastic tournaments results.The GGtoor Chill TCG Showdown started early on Sunday, December 13th, and Swiss rounds boasted 196 players. Some veterans to the Pokemon TCG tournament scene were in attendance, including Mike Fouchet – the defending GGtoor champion from our prior event, along with many new competitors on their first online event ever! Zacian, and Lutherwtj piloting Lucmetal Zacian. Both of these decks were not only utilizing Zacian V to its utmost potential,...

CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (the “Corporation” or “CEMATRIX”) a North American leading manufacturer and supplier of technologically advanced cellular concrete products announced that one of its wholly owned operating subsidiaries, which includes CEMATRIX (Canada) Inc. (“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout Company (“PIGCO’) has been awarded a record $23.5 million USD (approximately $30.1 million CDN) tunnel project.Factoring in a $2.7 million CDN reduction in previously reported total contracts, due mainly to a stronger Canadian dollar exchange rate and a $4.2 USD ($5.5 million CDN) project that was moved to strong possibility from a verbally awarded project, CEMATRIX’s total contracted and verbally awarded (mainly contracts in process) projects now...

NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) — WisdomTree (NASDAQ: WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, today announced the completion of the reorganization of the WisdomTree Continuous Commodity Index Fund (“CCIF”) into and with the WisdomTree Enhanced Commodity Strategy Fund. The Enhanced Commodity Strategy Fund is organized under the Investment Company Act of 1940, as amended, with no Schedule K-1 and an expense ratio of 0.55%. The Enhanced Commodity Strategy Fund will focus on providing broad-based exposure to a diversified basket of commodities through investment in futures contracts and trade under the ticker symbol “GCC”.   Jeremy Schwartz, WisdomTree Global Head of Research, said, “The macroeconomic backdrop as we emerge from lockdowns could bring higher inflation....

NEWTON, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced full enrollment of its pivotal trial evaluating the bioequivalence (BE) of ACER-001 compared to BUPHENYL® (sodium phenylbutyrate). Acer is developing ACER-001 for the treatment of urea cycle disorders (UCDs).The single-center, single-blind, randomized, single-dose crossover trial is designed to demonstrate the BE of ACER-001 compared to BUPHENYL® under fed conditions, in approximately 36 healthy adults. Results of the trial are expected in the first quarter of 2021.“We completed the first bridging study in the first quarter of 2020, the results of...

Financial calendar 2021 for Enalyzer A/S is as follows: 03.18.2021 Annual financial statement04.22.2021 Annual General Meeting08.25.2021 Half-yearly financial statement The financial calendar is published on www.enalyzer.com For further information on Enalyzer A/S, please contact: Enalyzer A/SJakob Roed Jakobsen,Co-Founder & Co-CEORefshalevej 147DK-1432 CopenhagenTelefon: +45 7010 7006E-mail: jakob.roed@enalyzer.com Certified AdvisorEYChristian Ejlskov, Executive Director | Local M&AOsvald Helmuths Vej 4DK-2000 FrederiksbergPhone: +45 7010 8050Email: Christian.Ejlskov@dk.ey.com Vedhæftet filFinancial-Calendar-2021

New trains manufactured in Hauts-de-France, certified Origine France Garantie, to modernize and improve services on the region’s busiest lines The OMNEO Regio 2N trains combine capacity, comfort and accessibilityBERLIN, Dec. 22, 2020 (GLOBE NEWSWIRE) —Note to editors: To view the photo associated with this press release, please visit the following link:https://www.globenewswire.com/NewsRoom/AttachmentNg/7677f2b6-376c-4707-b07f-695439affbc7Global mobility leader Bombardier Transportation has received an order for 33 BOMBARDIER OMNEO Regio 2N trains, from SNCF on behalf of the Hauts-de-France region. This new order amounts to approximately 565 million euro ($688 million US) and is part of the framework agreement signed with SNCF in 2010 to provide a maximum of 860 OMNEO Regio 2N trains to the French regions.The trains of this new...

Un train fabriqué dans les Hauts-de-France, certifié Origine France Garantie, pour moderniser les lignes les plus fréquentées de la régionLe train OMNEO Regio 2N allie avantageusement capacité, confort et accessibilitéBERLIN, 22 déc. 2020 (GLOBE NEWSWIRE) —Note aux rédacteurs : Pour voir la photo associée à ce communiqué, veuillez visiter le lien suivant :https://www.globenewswire.com/NewsRoom/AttachmentNg/7677f2b6-376c-4707-b07f-695439affbc7/frBombardier Transport, un chef de file mondial du secteur des technologies ferroviaires, a reçu une commande de 33 rames BOMBARDIER OMNEO Regio2N de SNCF pour le compte de la Région Hauts-de-France.Le budget voté par la Région s’élève à environ 565 millions d’euros (688 millions de dollars US) et s’inscrit dans le cadre du contrat signé entre Bombardier et SNCF en 2010 qui prévoit la fabrication...

MONTREAL, Dec. 22, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its Press Release dated December 8th, 2020, the Company has submitted a formal application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”). NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world’s best technology companies.In connection with its application to list on NASDAQ, PyroGenesis will, in due course, file a Form 40-F Registration Statement with...

AUSTIN, Texas, Dec. 22, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced the appointment of Dr. Peter Gammel, a well-respected RF industry thought leader, to its Advisory Board.Dr. Gammel joins Resonant’s Advisory Board with over 40 years of experience in the global semiconductor industry, having focused much of his career on differentiated device technology. Currently, Dr. Gammel serves as Chief Technology Officer of the MWI Strategic Business Unit of GlobalFoundries, the world’s leading specialty foundry. Previously, Dr. Gammel served as Chief Technology Officer at Skyworks Solutions, Inc.Dr. Gammel brings substantial experience in managing rapid-growth technology platforms...

-所获专利扩大和增强了Monopar目前的camsirubicin知识产权组合-针对晚期软组织瘤的camsirubicin2期试验在2021年初启动的安排保持不变伊利诺伊州威尔梅特, Dec. 22, 2020 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc.（纳斯达克股票代码：MNPR）是一家临床阶段生物制药公司，专注于开发延长癌症患者寿命或提高其生活质量的专利疗法。该公司今天宣布获得新型camsirubicin类似物配方的美国专利（US 10450340）。这项专利扩展了该公司camsirubicin知识产权组合，此项专利有效期截至2038年（不包含专利的任何延期）。“这项专利中包含的类似物从设计上旨在保留camsirubicin潜在有利的非心脏毒性化学结构和阿霉素的广谱抗肿瘤活性；此外，临床前证据表明，这一族新型2-pyrrilino camsirubicin类似物可能在对阿霉素耐药的肿瘤细胞中发挥作用。这让我们有可能治疗camsirubicin有效范围之外的其他更多的癌症类型，” Monopar首席科学官Andrew Mazar博士表示。阿霉素是美国食品和药品管理局批准的针对14种癌症的药物，包括软组织瘤和骨肉瘤、 转移性胃癌、卵巢癌、甲状腺癌、肺癌和乳腺癌；急性髓细胞白血病和淋巴细胞白血病；霍奇金和非霍奇金淋巴瘤；以及神经母细胞瘤。 但是，阿霉素的累积剂量作用可导致不可逆的心脏损伤和死亡，因此对这种药物的使用设置了限制性的终生累积剂量上限。“如果试验成功，camsirubicin及其类似物可以突破限制性使用剂量，与阿霉素相比可以按更高剂量和更长时间给药”，Monopar首席执行官Chandler Robinson博士表示。“这有可能提高疗效并改善患者的治疗效果。”Monopar的临床试验合作伙伴是专注于肉瘤治疗药物研究和开发的国际知名非营利组织Grupo Español de Investigación...